Pharmacokinetics of WR-2721
- 1 January 1988
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 39 (1-3) , 195-201
- https://doi.org/10.1016/0163-7258(88)90061-7
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapyPharmacology & Therapeutics, 1988
- Can WR-2721 be improved upon?Pharmacology & Therapeutics, 1988
- Bioavailability and newer methods of delivery of phosphorothioate radioprotectorsPharmacology & Therapeutics, 1988
- Rat liver alkaline phosphatasesDigestive Diseases and Sciences, 1985
- Cystine depletion by WR-1065 in cystinotic cellsBiochemical Pharmacology, 1985
- Toxicity of WR-2721 administered in single and multiple dosesInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Radioprotection of mouse skin by WR-2721: The critical influence of oxygen tensionInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Radiobiological and Biochemical Studies of Thiophosphate Radioprotective Compounds Related to CysteamineRadiation Research, 1971
- Enzymic Hydrolysis of Cysteamine S-Phosphate by Human Erythrocytes.Acta Chemica Scandinavica, 1960
- Protection Contre le Rayonnement X par la β-MercaptoéthylamineArchives Internationales de Physiologie, 1951